Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice

Neuron

Volumn 81, Issue 1, 2014, Pages 77-90

  Castellan Baldan, Lissandra ^a   Williams, KyleA ^a,b   Gallezot, Jean Dominique ^a   Pogorelov, Vladimir ^a   Rapanelli, Maximiliano ^a   Crowley, Michael ^b   Anderson, GeorgeM ^a,b   Loring, Erin ^a,b   Gorczyca, Roxanne ^c   Billingslea, Eileen ^a   Wasylink, Suzanne ^a   Panza, KaitlynE ^b   Ercan Sencicek, A Gulhan ^a,b   Krusong, Kuakarun ^a,d   Leventhal, BennettL ^e,f   Ohtsu, Hiroshi ^g   Bloch, MichaelH ^a,b   Hughes, ZoëA ^c   Krystal, JohnH ^a   Mayes, Linda ^a,b   deAraujo, Ivan ^a,h   Ding, Yu Shin ^a,i   State, MatthewW ^a,b,j   Pittenger, Christopher ^a,b   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g TOHOKU UNIVERSITY   (Japan)

^h JOHN B PIERCE LABORATORY   (United States)

ⁱ NEW YORK UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; HALOPERIDOL; HISTAMINE; PROTEIN FOS; DOPAMINE; HISTIDINE DECARBOXYLASE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; BIOSYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME DEFICIENCY; GENE MUTATION; GILLES DE LA TOURETTE SYNDROME; HISTIDINE DECARBOXYLASE DEFICIENCY; HUMAN; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; PHENOMENOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; RECEPTOR BINDING; SENSORY GATING; STEREOTYPING; STEREOTYPY; TIC; UPREGULATION; ANIMAL MODEL; ANIMAL TISSUE; BRAIN TISSUE; CLINICAL ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG DOSE COMPARISON; ELEVATED PLUS MAZE TEST; FOS GENE; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; KNOCKOUT MOUSE; MOLECULAR INTERACTION; NEUROPATHOLOGY; OPEN FIELD BEHAVIOR; PATHOGENESIS; STARTLE REFLEX;

ADOLESCENT; ADULT; AMPHETAMINE; ANIMALS; BRAIN; CHILD; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXPLORATORY BEHAVIOR; FEMALE; HISTIDINE DECARBOXYLASE; HUMANS; MALE; MAZE LEARNING; MICE; MICE, KNOCKOUT; MIDDLE AGED; MUTATION; OXAZINES; RACLOPRIDE; STEREOTYPED BEHAVIOR; TIME FACTORS; TOURETTE SYNDROME; TRYPTOPHAN; YOUNG ADULT;

EID: 84891760813     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.10.052     Document Type: Article

References (86)

1. Acevedo S.F., Ohtsu H., Benice T.S., Rizk-Jackson A., Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res. 2006, 1071:113-123.
2. Ahmari S.E., Risbrough V.B., Geyer M.A., Simpson H.B. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology 2012, 37:1216-1223.
3. Albin R.L. Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function. Adv. Neurol. 2006, 99:99-106.
4. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12:366-375.
5. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
6. Baldan Ramsey L.C., Xu M., Wood N., Pittenger C. Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 2011, 180:222-228.
7. Bloch M.H. Emerging treatments for Tourette's disorder. Curr. Psychiatry Rep. 2008, 10:323-330.
8. Bloch M., State M., Pittenger C. Recent advances in Tourette syndrome. Curr. Opin. Neurol. 2011, 24:119-125.
9. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
10. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat. Neurosci. 2000, 3:377-383.
11. Carson R.E., Barker W., Liow J.-S., Johnson C. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. Nuclear Science Symposium Conference Record, 2003 IEEE 2003, 5:3281-3285.
12. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol. Psychiatry 1996, 39:33-41.
13. Choi E.Y., Yeo B.T., Buckner R.L. The organization of the human striatum estimated by intrinsic functional connectivity. J.Neurophysiol. 2012, 108:2242-2263.
14. Crittenden J.R., Graybiel A.M. Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Frontiers in neuroanatomy 2011, 5:59.
15. Davis L.K., Yu D., Keenan C.L., Gamazon E.R., Konkashbaev A.I., Derks E.M., Neale B.M., Yang J., Lee S.H., Evans P., et al. Partitioning the heritability of tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 2013, 9:e1003864.
16. de Leeuw A.S., Oranje B., van Megen H.J., Kemner C., Westenberg H.G. Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients. Int. Clin. Psychopharmacol. 2010, 25:232-240.
17. Dere E., De Souza-Silva M.A., Topic B., Spieler R.E., Haas H.L., Huston J.P. Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo- and ventro-striatal dopamine turnover. Learn. Mem. 2003, 10:510-519.
18. Dere E., De Souza-Silva M.A., Spieler R.E., Lin J.S., Ohtsu H., Haas H.L., Huston J.P. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur. J. Neurosci. 2004, 20:1051-1058.
19. Du J.C., Chiu T.F., Lee K.M., Wu H.L., Yang Y.C., Hsu S.Y., Sun C.S., Hwang B., Leckman J.F. Tourette syndrome in children: an updated review. Pediatr. Neonatol. 2010, 51:255-264.
20. Ellender T.J., Huerta-Ocampo I., Deisseroth K., Capogna M., Bolam J.P. Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. J.Neurosci. 2011, 31:15340-15351.
21. Ercan-Sencicek A.G., Stillman A.A., Ghosh A.K., Bilguvar K., O'Roak B.J., Mason C.E., Abbott T., Gupta A., King R.A., Pauls D.L., et al. L-histidinedecarboxylase and Tourette's syndrome. N.Engl. J. Med. 2010, 362:1901-1908.
22. Fasano S., Pittenger C., Brambilla R. Inhibition of CREB activity in the dorsal portion of the striatum potentiates behavioral responses to drugs of abuse. Front. Behav. Neurosci 2009, 3:29. 10.3389/neuro.08.029.2009.
23. Fauchey V., Jaber M., Caron M.G., Bloch B., Le Moine C. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur. J. Neurosci. 2000, 12:19-26.
24. Fernandez T.V., Sanders S.J., Yurkiewicz I.R., Ercan-Sencicek A.G., Kim Y.S., Fishman D.O., Raubeson M.J., Song Y., Yasuno K., Ho W.S., et al. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol. Psychiatry 2012, 71:392-402.
25. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders: Clinical Version (SCID-CV) 1997, American Psychiatric Press, Washington, DC.
26. Flik G., Dremencov E., Cremers T.I., Folgering J.H., Westerink B.H. The role of cortical and hypothalamic histamine-3 receptors in the modulation of central histamine neurotransmission: an invivo electrophysiology and microdialysis study. Eur. J. Neurosci. 2011, 34:1747-1755.
27. Fray P.J., Sahakian B.J., Robbins T.W., Koob G.F., Iversen S.D. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacology (Berl.) 1980, 69:253-259.
28. Graff-Guerrero A., Willeit M., Ginovart N., Mamo D., Mizrahi R., Rusjan P., Vitcu I., Seeman P., Wilson A.A., Kapur S. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans. Hum. Brain Mapp. 2008, 29:400-410.
29. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu. Rev. Neurosci. 2008, 31:359-387.
30. Grillner S., Robertson B., Stephenson-Jones M. The evolutionary origin of the vertebrate basal ganglia and its role in action selection. J.Physiol. 2013, 591:5425-5431.
31. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev. 2008, 88:1183-1241.
32. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
33. Hoenig K., Hochrein A., Quednow B.B., Maier W., Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol. Psychiatry 2005, 57:1153-1158.
34. Ichise M., Toyama H., Innis R.B., Carson R.E. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J.Cereb. Blood Flow Metab. 2002, 22:1271-1281.
35. Jankovic J., Kurlan R. Tourette syndrome: evolving concepts. Mov. Disord. 2011, 26:1149-1156.
36. Joshi V.V., Balsara J.J., Jadhav J.H., Chandorkar A.G. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice. Eur. J. Pharmacol. 1981, 69:499-502.
37. Kalivas P.W. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J.Pharmacol. Exp. Ther. 1982, 222:37-42.
38. Kamei C., Dabasaki T., Tasaka K. Cataleptic effect of histamine induced by intraventricular injection in mice. Jpn. J. Pharmacol. 1983, 33:1081-1084.
39. Kamei C., Dabasaki T., Tasaka K. Effect of intraventricular injection of histamine on the pinna reflex in mice. Jpn. J. Pharmacol. 1984, 35:193-195.
40. Karagiannidis I., Dehning S., Sandor P., Tarnok Z., Rizzo R., Wolanczyk T., Madruga-Garrido M., Hebebrand J., Nöthen M.M., Lehmkuhl G., et al. Support of the histaminergic hypothesis in Tourette Syndrome: association of the histamine decarboxylase gene in a large sample of families. J.Med. Genet. 2013, 50:760-764.
41. Kelley A.E. Measurement of rodent stereotyped behavior. Curr. Protoc. Neurosci. 2001, 8:8.8. 10.1002/0471142301.ns0808s04.
42. Kitanaka J., Kitanaka N., Tatsuta T., Morita Y., Takemura M. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors. Neuroscience 2007, 147:765-777.
43. Kitanaka J., Kitanaka N., Tatsuta T., Miyoshi A., Koumoto A., Tanaka K., Nishiyama N., Morita Y., Takemura M. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice. Pharmacol. Biochem. Behav. 2010, 94:464-470.
44. Kohl S., Heekeren K., Klosterkötter J., Kuhn J. Prepulse inhibition in psychiatric disorders-apart from schizophrenia. J.Psychiatr. Res. 2013, 47:445-452.
45. Krusong K., Ercan-Sencicek A.G., Xu M., Ohtsu H., Anderson G.M., State M.W., Pittenger C. High levels of histidine decarboxylase in the striatum of mice and rats. Neurosci. Lett. 2011, 495:110-114.
46. Kurlan R. Clinical practice. Tourette's Syndrome. N.Engl. J. Med. 2010, 363:2332-2338.
47. Kwak C.H., Jankovic J. Tourettism and dystonia after subcortical stroke. Movement disorders: official journal of the Movement Disorder Society 2002, 17:821-825.
48. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., Cohen D.J. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J.Am. Acad. Child Adolesc. Psychiatry 1989, 28:566-573.
49. Leckman J.F., Bloch M.H., Smith M.E., Larabi D., Hampson M. Neurobiological substrates of Tourette's disorder. J.Child Adolesc. Psychopharmacol. 2010, 20:237-247.
50. Lee A.S., Duman R.S., Pittenger C. A double dissociation revealing bidirectional competition between striatum and hippocampus during learning. Proc. Natl. Acad. Sci. USA 2008, 105:17163-17168.
51. Lipschitz D.S., Mayes L.M., Rasmusson A.M., Anyan W., Billingslea E., Gueorguieva R., Southwick S.M. Baseline and modulated acoustic startle responses in adolescent girls with posttraumatic stress disorder. J.Am. Acad. Child Adolesc. Psychiatry 2005, 44:807-814.
52. McCairn K.W., Bronfeld M., Belelovsky K., Bar-Gad I. The neurophysiological correlates of motor tics following focal striatal disinhibition. Brain 2009, 132:2125-2138.
53. Mink J.W. Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?. Adv. Neurol. 2001, 85:113-122.
54. Narendran R., Slifstein M., Guillin O., Hwang Y., Hwang D.R., Scher E., Reeder S., Rabiner E., Laruelle M. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist invivo. Synapse 2006, 60:485-495.
55. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
56. O'Rourke J.A., Scharf J.M., Yu D., Pauls D.L. The genetics of Tourette syndrome: a review. J.Psychosom. Res. 2009, 67:533-545.
57. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., Tchougounova E., Hellman L., Gertsenstein M., Hirasawa N., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 2001, 502:53-56.
58. Onodera K., Ogura Y. Advances in histamine research. Advances in Histamine Research 1981, 127-136. Pergamon Press, Oxford. B. Uvnäs, K. Tasaka (Eds.).
59. Paul V.N., Chopra K., Kulkarni S.K. Modulation of motor functions involving central dopaminergic system by L-histidine. Indian J. Exp. Biol. 2000, 38:988-993.
60. Payer D.E., Behzadi A., Kish S.J., Houle S., Wilson A.A., Rusjan P.M., Tong J., Selby P., George T.P., McCluskey T., Boileau I. Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [(11)C]-(+)-PHNO. Neuropsychopharmacology 2013, Published online August 7, 2013. 10.1038/npp.2013.192.
61. Pittenger C. Pathophysiological modeling of obsessive-compulsive disorder: challenges, and progress. Biol. Psychiatry 2011, 70:1002-1003.
62. Rabiner E.A., Slifstein M., Nobrega J., Plisson C., Huiban M., Raymond R., Diwan M., Wilson A.A., McCormick P., Gentile G., et al. Invivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. Synapse 2009, 63:782-793.
63. Rankin M.L., Hazelood L.A., Free R.B., Namkung Y., Rex E.B., Roof R.A., Sibley D.R. Molecular pharmacology of the dopamine receptors. The Dopamine Handbook 2010, 63-87. Oxford University Press, New York. L.L. Iversen, S.B. Dunnett, S.D. Iversen, A. Bjorkund (Eds.).
64. Scharf J.M., Yu D., Mathews C.A., Neale B.M., Stewart S.E., Fagerness J.A., Evans P., Gamazon E., Edlund C.K., Service S.K., et al. Genome-wide association study of Tourette's syndrome. Mol. Psychiatry 2013, 18:721-728. Published online August 14, 2012. 10.1038/mp.2012.69.
65. Schlicker E., Malinowska B., Kathmann M., Göthert M. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam. Clin. Pharmacol. 1994, 8:128-137.
66. Shmelkov S.V., Hormigo A., Jing D., Proenca C.C., Bath K.G., Milde T., Shmelkov E., Kushner J.S., Baljevic M., Dincheva I., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat. Med. 2010, 16:598-602.
67. Singer H.S., Szymanski S., Giuliano J., Yokoi F., Dogan A.S., Brasic J.R., Zhou Y., Grace A.A., Wong D.F. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am. J. Psychiatry 2002, 159:1329-1336.
68. Stanwood G.D., Artymyshyn R.P., Kung M.P., Kung H.F., Lucki I., McGonigle P. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J.Pharmacol. Exp. Ther. 2000, 295:1223-1231.
69. Stanwood G.D., Lucki I., McGonigle P. Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. J.Pharmacol. Exp. Ther. 2000, 295:1232-1240.
70. State M.W. The genetics of Tourette disorder. Curr. Opin. Genet. Dev. 2011, 21:302-309.
71. Swerdlow N.R. Update: Studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci. Biobehav. Rev. 2012.
72. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol. Psychiatry 2001, 50:578-585.
73. Takagi H., Morishima Y., Matsuyama T., Hayashi H., Watanabe T., Wada H. Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker. Brain Res. 1986, 364:114-123.
74. Tellez L.A., Medina S., Han W., Ferreira J.G., Licona-Limón P., Ren X., Lam T.T., Schwartz G.J., de Araujo I.E. A gut lipid messenger links excess dietary fat to dopamine deficiency. Science 2013, 341:800-802.
75. Terrados G., Finkernagel F., Stielow B., Sadic D., Neubert J., Herdt O., Krause M., Scharfe M., Jarek M., Suske G. Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. Nucleic Acids Res. 2012, 40:7844-7857.
76. Traiffort E., Leurs R., Arrang J.M., Tardivel-Lacombe J., Diaz J., Schwartz J.C., Ruat M. Guinea pig histamine H1 receptor. I. Gene cloning, characterization, and tissue expression revealed by insitu hybridization. J.Neurochem. 1994, 62:507-518.
77. Traiffort E., Vizuete M.L., Tardivel-Lacombe J., Souil E., Schwartz J.C., Ruat M. The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart. Biochem. Biophys. Res. Commun. 1995, 211:570-577.
78. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007, 33:69-94.
79. Tziortzi A.C., Searle G.E., Tzimopoulou S., Salinas C., Beaver J.D., Jenkinson M., Laruelle M., Rabiner E.A., Gunn R.N. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 2011, 54:264-277.
80. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
81. Welch J.M., Lu J., Rodriguiz R.M., Trotta N.C., Peca J., Ding J.D., Feliciano C., Chen M., Adams J.P., Luo J., et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448:894-900.
82. White F.J., Wang R.Y. A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci. 1984, 34:1161-1170.
83. Williams K., Bloch M.H., State M., Pittenger C. Tourette syndrome and tic disorders. Neurobiology of Mental Illness 2013, 1048-1060. Oxford University Press, New York. Fourth Edition. D.S. Charney, E.J. Nestler, P. Sklar, J.D. Buxbaum (Eds.).
84. Wong D.F., Brasić J.R., Singer H.S., Schretlen D.J., Kuwabara H., Zhou Y., Nandi A., Maris M.A., Alexander M., Ye W., et al. Mechanisms ofdopaminergic and serotonergic neurotransmission in Tourette syndrome:clues from an invivo neurochemistry study with PET. Neuropsychopharmacology 2008, 33:1239-1251.
85. Young S.T., Porrino L.J., Iadarola M.J. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA 1991, 88:1291-1295.
86. Zhou F.W., Xu J.J., Zhao Y., LeDoux M.S., Zhou F.M. Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata. J.Neurophysiol. 2006, 96:1581-1591.